LOSEC

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Spain, Finland, Hong Kong, Ireland, Israel, Italy, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, United Kingdom, South Africa

Active ingredients

The drug LOSEC contains one active pharmaceutical ingredient (API):

1 Omeprazole UNII KG60484QX9 - OMEPRAZOLE

Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing. Read about Omeprazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOSEC Capsule, Tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A02BC01	Omeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11677N, 12270T, 8332M, 9109K, 9110L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502302301117211, 502302302113211, 502302303111210, 502302304116216, 502315030023603, 502315030023703
Country: CA	Health Products and Food Branch	Identifier(s): 00846503, 02190915
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 58377
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 016220, 016428, 081512, 081523, 513051
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139262, 139264, 139266, 139269, 14251, 14262, 14287, 143329, 143357, 143370, 143372, 143666, 14766, 14768, 14773, 175688, 196959, 199672, 199674, 199676, 199678, 199679, 199681, 381471, 387240, 399685
Country: HK	Department of Health Drug Office	Identifier(s): 44353, 44354
Country: IE	Health Products Regulatory Authority	Identifier(s): 32120, 32130, 32141, 32162, 32173, 65532, 66918, 66919
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 1388, 3266, 5221, 5222
Country: IT	Agenzia del Farmaco	Identifier(s): 026804082, 026804106
Country: MT	Medicines Authority	Identifier(s): AA1411/02301, MA639/03401
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 245M2003
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 50407, 50415, 50423
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13936, 4803, 4806, 4807, 8346, 8347
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100189833
Country: SG	Health Sciences Authority	Identifier(s): 10699P, 10700P, 13562P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/11.4.3/0410, 32/11.4.3/0222, 32/11.4.3/0223, 32/11.4.3/0224, V/11.4.3/193, Z/11.4.3/98